van Leeuwen FE et al., 1994-02: Dutch 1,939-patient Hodgkin cohort treated 1966-1986. The 20-year actuarial risk of any second cancer was 20%; leukaemia risk was 2.1% at 10 years for 1980s chemotherapy versus 6.4% for 1970s chemotherapy.
Patients treated with CT in the 1980s had a substantially lower risk of leukemia than patients treated in the 1970s (10-year actuarial risks of 2.1% and 6.4%, respectively; P = .07).
Abstract (Results)
van Leeuwen FE et al., 1994-02: Dutch 1,939-patient Hodgkin cohort treated 1966-1986. The 20-year actuarial risk of any second cancer was 20%; leukaemia risk was 2.1% at 10 years for 1980s chemotherapy versus 6.4% for 1970s chemotherapy. Closest real JCO source for a '2% to 3%' figure: 2.1% is a 10-YEAR actuarial LEUKAEMIA risk for 1980s chemotherapy, not a 15-year cumulative risk for all second cancers. The '2% to 3% at 15 years' wording in the book is therefore misattributed if this is the intended source. Comparator: chemotherapy era (1970s vs 1980s) and cohort vs general population (RR 3.5 for all second cancers; RR 34.7 for leukaemia). Funder/COI not in the abstract.
